With 110 days left in 2018, Resverlogix predicted end of dosing (hitting 250 events) by end of 2018 and top line read out Q1 2019.

With 55 days left in 2018, Resverlogix predicted end of dosing (hitting 250 events) by end of 2018 and top line read out Q1 2019.

With 12 days left in 2018, Dr. Michael Sweeney stated "We are now accruing the final events – to yield at least 250 pre-specified MACE events – prior to study completion"

We are now 25 days into 2019. 

What's the deal? Have they hit 250 yet or not?

Is it reasonable to think that Resverlgoix will announce hitting 250 events and last dosing so that we know when the adjudication and last patient visit processes begin?

BearDownAZ